Bodisen Snapshot
  Board & Management
  Enterprise Honor
  Enterprise Culture
  Innovation to Feed China's Expanding Population
Bodisen Biotech, Inc.
"Forbes China Ranks Bodisen a Top 100 Growth Company"
Jan 2006, Forbes China
  • We are a US public company with our main business in China
    We are registered in Delaware that engages in the research, manufacturing and marketing of proprietary technology based environmentally friendly fertilizers targeting the $17 billion per year Chinese fertilizer industry.
  • Our shares are quoted on the Pink Sheets (stock symbol: BBCZ) and dual listed on the London Stock Exchange AIM market (stock symbol: BODI)
    Through an IPO that was completed in February 2006 with Deloitte & Touche as reporting accountant and global law firms as legal advisors, Bodisen became the largest (market cap) China based company listed on the AIM market. Our 12 million British Pound dual listing IPO offering was 3.5 times over subscribed by UK institutional investors. Bodisen is in good listing compliance under both US and UK regulations.
  • We provide environmentally friendly fertilizers to China's 900 million farmers
    With over 60 products and approximately 600 national distribution centers and growing, Bodisen has experienced rapid growth in recent years. Our products have been proven to increase crop yields by 10% to 35%, substantially improving the lifestyles of Chinese farmers whose livelihood are solely dependent upon their crop yields. In January 2006, Forbes China ranked Bodisen the 16th fastest growing company in China. In January 2005, Bodisen was ranked the 94th fastest growing company in China.
  • Our products have strong demand from Chinese farmers
    Bodisen products are not only environment-friendly, but in a country striving to diminish its dependency on imports, it improves crop yields dramatically. Bodisen's products are based on proprietary technologies and have been developed by the Company's founder and President Mr. Bo Chen and its team of scientists in collaboration with scientists at local university laboratories.
  • We are a company with strong growth and earnings (in US dollars)
    2003: Revenue - $9.8 million; Net income: $1.97 million
    2004: Revenue - $16.23 million; Net income: $5.05 million
    2005: Revenue - $30.98 million; Net income: $7.43 million
    2006 - 1Q: Revenue: $10.54 million; Net income: $2.68 million

Copyright © 2004-2012